The Gastroenterologist's Guide to Preventive Management of Compensated Cirrhosis
Overview
Authors
Affiliations
Despite advances in medical care, the prevalence and mortality associated with cirrhosis continue to rise. The majority of medical care and physician efforts are devoted to the management of decompensated cirrhosis and its complications of gastrointestinal hemorrhage, hepatic encephalopathy, and ascites; however, limited efforts are placed on the medical management of compensated cirrhosis. Patients with compensated cirrhosis carry a higher survival rate, and, when diagnosed early, may be screened for future decompensation. When possible, these patients can be treated for their underlying disease to prevent disease progression and avoid the need for liver transplantation. This article reviews the importance of early diagnosis, outpatient management of compensated cirrhosis, early screening for potential decompensation, and patient education.
Top-Down Proteomics Identifies Plasma Proteoform Signatures of Liver Cirrhosis Progression.
Forte E, Sanders J, Pla I, Kanchustambham V, Hollas M, Huang C Mol Cell Proteomics. 2024; 23(12):100876.
PMID: 39521382 PMC: 11664408. DOI: 10.1016/j.mcpro.2024.100876.
Top-Down Proteomics Identifies Plasma Proteoform Signatures of Liver Cirrhosis Progression.
Forte E, Sanders J, Pla I, Kanchustambham V, Hollas M, Huang C bioRxiv. 2024; .
PMID: 38948836 PMC: 11212939. DOI: 10.1101/2024.06.19.599662.
Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments.
Petagine L, Zariwala M, Patel V World J Gastroenterol. 2023; 29(32):4831-4850.
PMID: 37701135 PMC: 10494768. DOI: 10.3748/wjg.v29.i32.4831.
Thieu H, Minh T, Tuong T, Duc N Med Arch. 2022; 76(2):122-126.
PMID: 35774043 PMC: 9233469. DOI: 10.5455/medarh.2022.76.122-126.
Ames J, Djerboua M, Terrault N, Booth C, Flemming J Can J Gastroenterol Hepatol. 2022; 2022:6175913.
PMID: 35308801 PMC: 8926479. DOI: 10.1155/2022/6175913.